VIA Pharmaceuticals Announces Upcoming Investor Conference Pre... ( SAN FRANCISCO Nov. 4 /- VIA Pharm...)

VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations

Date:11/4/2008

SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that VIA management will present at three upcoming investor conferences.

The presentation details are as follows:

Rodman & Renshaw Annual Global Investment Conference

Wednesday, November 12, 2008, 10:20 a.m. ET

New York, NY

Lazard Capital Markets Healthcare Conference

Wednesday, November 19, 2008, 11:30 a.m. ET

New York, NY

20th Annual Piper Jaffray Health Care Conference

Tuesday, December 2, 2008, 4:00 p.m. ET

New York, NY

Interested parties may access live audio webcasts of the presentations from the investor section of the VIA website, http://www.viapharmaceuticals.com. Replays of the presentations will be archived on the VIA website for at least one week following each presentation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.

0

GOOD

Page: 1
Related biology technology :

1. OncoMed Pharmaceuticals Completes Series B Financing
2. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
3. Genesis Pharmaceuticals Launches New Corporate Website
4. Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation
5. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
6. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
7. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
8. Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
9. Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)
10. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
11. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008

Post Your Comments:

VIA Pharmaceuticals Announces Upcoming Investor Conference Pre...( SAN FRANCISCO Nov. 4 /- VIA Pharm...)